Clario to acquire WCG's eCOA Business

Company

Location

About

Whether you’re running a cardiac safety, eCOA/ePRO, respiratory or imaging trial, Clario’s Science and Operational teams can advise on how to advance your trial forward. Learn more: https://clario.com/accelerating-clinical-trial-study-setup-time/ Clario is a leading healthcare research and technology company that generates the richest clinical evidence in the industry for our pharmaceutical, biotech and medical device partners. Across decentralized, hybrid and site-based trials, our deep scientific expertise, global scale and the broadest endpoint technology platform in the industry allows our partners to transform lives. Clario has the only technology platform that combines eCOA, cardiac safety, medical imaging, precision motion, and respiratory endpoints. With 30 facilities in nine countries, Clario's global team of science, technology and operational experts has helped deliver over 19,000 trials and 870 regulatory approvals for over five million patients in 120 countries. Our innovation has been transforming clinical trials for 50 years. Visit https://clario.com/ for more information.